Lista de obras - M Meregalli - Dominio Público Uruguay

Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model.

artículo científico publicado en 2012

CD133(+) cells isolated from various sources and their role in future clinical perspectives

artículo científico publicado en 2010

CD20-related signaling pathway is differently activated in normal and dystrophic circulating CD133+ stem cells

artículo científico publicado en 2009

Cell based therapy for Duchenne muscular dystrophy

artículo científico publicado en 2009

Clinical applications of mesenchymal stem cells in chronic diseases

artículo científico publicado en 2014

Cognitive disorders in the elderly. Genetic and epigenetic aspects

artículo científico publicado en 2001

Combining stem cells and exon skipping strategy to treat muscular dystrophy

artículo científico publicado en 2008

Correlation of circulating CD133+ progenitor subclasses with a mild phenotype in Duchenne muscular dystrophy patients

artículo científico publicado en 2008

Ex vivo expansion of human circulating myogenic progenitors on cluster-assembled nanostructured TiO2.

artículo científico publicado en 2010

Expression of CD20 reveals a new store-operated calcium entry modulator in skeletal muscle

artículo científico publicado en 2012

Expression of parathyroid-specific genes in vascular endothelial progenitors of normal and tumoral parathyroid glands

artículo científico publicado en 2009

Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells

artículo científico publicado en 2013

Hmgb3 is regulated by microRNA-206 during muscle regeneration

artículo científico publicado en 2012

Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle

Improvement of endurance of DMD animal model using natural polyphenols.

artículo científico publicado en 2015

In vivo tracking of stem cell by nanotechnologies: future prospects for mouse to human translation

artículo científico publicado en 2010

Influence of immune responses in gene/stem cell therapies for muscular dystrophies

artículo científico publicado en 2014

Novel insight into stem cell trafficking in dystrophic muscles.

artículo científico publicado en 2012

Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy.

artículo científico publicado en 2010

Perspectives of stem cell therapy in Duchenne muscular dystrophy

artículo científico publicado en 2013

Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice

artículo científico publicado en 2007

Skin-derived stem cells transplanted into resorbable guides provide functional nerve regeneration after sciatic nerve resection.

artículo científico publicado en 2007

Stem cell therapies to treat muscular dystrophy: progress to date

artículo científico publicado en 2010

The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease

artículo científico publicado en 2001

The role of stem cells in muscular dystrophies

artículo científico

VCAM-1 expression on dystrophic muscle vessels has a critical role in the recruitment of human blood-derived CD133+ stem cells after intra-arterial transplantation

artículo científico publicado en 2006

Lista de obras de M Meregalli

Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model.

CD133(+) cells isolated from various sources and their role in future clinical perspectives

CD20-related signaling pathway is differently activated in normal and dystrophic circulating CD133+ stem cells

Cell based therapy for Duchenne muscular dystrophy

Clinical applications of mesenchymal stem cells in chronic diseases

Cognitive disorders in the elderly. Genetic and epigenetic aspects

Combining stem cells and exon skipping strategy to treat muscular dystrophy

Correlation of circulating CD133+ progenitor subclasses with a mild phenotype in Duchenne muscular dystrophy patients

Ex vivo expansion of human circulating myogenic progenitors on cluster-assembled nanostructured TiO2.

Expression of CD20 reveals a new store-operated calcium entry modulator in skeletal muscle

Expression of parathyroid-specific genes in vascular endothelial progenitors of normal and tumoral parathyroid glands

Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells

Hmgb3 is regulated by microRNA-206 during muscle regeneration

Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle

Improvement of endurance of DMD animal model using natural polyphenols.

In vivo tracking of stem cell by nanotechnologies: future prospects for mouse to human translation

Influence of immune responses in gene/stem cell therapies for muscular dystrophies

Novel insight into stem cell trafficking in dystrophic muscles.

Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy.

Perspectives of stem cell therapy in Duchenne muscular dystrophy

Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice

Skin-derived stem cells transplanted into resorbable guides provide functional nerve regeneration after sciatic nerve resection.

Stem cell therapies to treat muscular dystrophy: progress to date

The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease

The role of stem cells in muscular dystrophies

VCAM-1 expression on dystrophic muscle vessels has a critical role in the recruitment of human blood-derived CD133+ stem cells after intra-arterial transplantation